Exelixis (EXEL) Prepaid Assets (2010 - 2026)
Exelixis (EXEL) posted quarterly Prepaid Assets of $75.9 million for Q2 2026, up 29.27% year-over-year from $58.7 million in Q2 2025, and little changed quarter-over-quarter from $75.6 million in Q1 2026.
Analysis
Exelixis (EXEL) Prepaid Assets (2010 - 2026) Analysis & Trends
Exelixis' Prepaid Assets history runs 17 years deep, the most recent figure standing at $75.9 million for Q2 2026.
- In Q2 2026, Prepaid Assets rose 29.27% year-over-year to $75.9 million; the TTM figure through Apr 2026 stood at $75.9 million (up 29.27% YoY), while the FY2026 annual figure was $75.6 million, up 10.39% from the prior year.
- Prepaid Assets for Q2 2026 stood at $75.9 million, roughly flat from $75.6 million in the prior quarter.
- The five-year high for Prepaid Assets was $76.6 million in Q4 2025, with the low at $48.3 million in Q3 2022.
- The 5-year median for Prepaid Assets is $66.9 million (2023), against an average of $64.7 million.
- The sharpest annual moves came in 2025 and 2026: Prepaid Assets slipped 13.03% in 2025, then advanced 29.27% in 2026.
- Exelixis' Prepaid Assets stood at $62.2 million in 2022, then grew by 9.19% to $67.9 million in 2023, then gained by 2.81% to $69.8 million in 2024, then gained by 9.68% to $76.6 million in 2025, then dropped by 0.94% to $75.9 million in 2026.
- Business Quant data shows EXEL's Prepaid Assets at $75.9 million in Q2 2026, $75.6 million in Q1 2026, and $76.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Exelixis | 14.81 Bn | 13.97 Bn | 608.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 60.50 Mn |
| Apr 3, 2026 | 75.88 Mn |
| Jan 2, 2026 | 75.60 Mn |
| Oct 3, 2025 | 76.60 Mn |
| Jul 4, 2025 | 73.83 Mn |
| Apr 4, 2025 | 58.70 Mn |
| Jan 3, 2025 | 68.48 Mn |
| Sep 27, 2024 | 69.84 Mn |
| Jun 28, 2024 | 58.25 Mn |
| Mar 29, 2024 | 67.49 Mn |
| Dec 29, 2023 | 67.93 Mn |
| Sep 29, 2023 | 66.89 Mn |
| Jun 30, 2023 | 62.26 Mn |
| Mar 31, 2023 | 60.65 Mn |
| Dec 30, 2022 | 62.21 Mn |
| Sep 30, 2022 | 52.90 Mn |
| Jul 1, 2022 | 48.28 Mn |
| Apr 1, 2022 | 53.33 Mn |
| Dec 31, 2021 | 57.53 Mn |
| Oct 1, 2021 | 51.56 Mn |